Ababneh, O.; Ghazou, A.; Alawajneh, M.; Alhaj Mohammad, S.; Bani-Hani, A.; Alrabadi, N.; Shreenivas, A.
The Efficacy and Safety of Immune Checkpoint Inhibitors in Adrenocortical Carcinoma: A Systematic Review and Meta-Analysis. Cancers 2024, 16, 900.
https://doi.org/10.3390/cancers16050900
AMA Style
Ababneh O, Ghazou A, Alawajneh M, Alhaj Mohammad S, Bani-Hani A, Alrabadi N, Shreenivas A.
The Efficacy and Safety of Immune Checkpoint Inhibitors in Adrenocortical Carcinoma: A Systematic Review and Meta-Analysis. Cancers. 2024; 16(5):900.
https://doi.org/10.3390/cancers16050900
Chicago/Turabian Style
Ababneh, Obada, Alina Ghazou, Mohmmad Alawajneh, Saleh Alhaj Mohammad, Abdullah Bani-Hani, Nasr Alrabadi, and Aditya Shreenivas.
2024. "The Efficacy and Safety of Immune Checkpoint Inhibitors in Adrenocortical Carcinoma: A Systematic Review and Meta-Analysis" Cancers 16, no. 5: 900.
https://doi.org/10.3390/cancers16050900
APA Style
Ababneh, O., Ghazou, A., Alawajneh, M., Alhaj Mohammad, S., Bani-Hani, A., Alrabadi, N., & Shreenivas, A.
(2024). The Efficacy and Safety of Immune Checkpoint Inhibitors in Adrenocortical Carcinoma: A Systematic Review and Meta-Analysis. Cancers, 16(5), 900.
https://doi.org/10.3390/cancers16050900